Good morning!
Here are the top stories to start your day.
For more updates on F&O. Click here.
⭐ Zydus Lifesciences receives USFDA nod
Pharma company has received approval from the USFDA to market generic drugs apixaban and olmesartan medoxomil & hydrochlorothiazide tablets. Both drugs had annual sales of $18,876 million and $41.7 million, respectively in the United States.
⭐ India’s core sector output rises
India’s core industrial output registered a 7.8% growth in January 2023, against a 4% growth during the same period last year. The core sector comprises eight key infrastructure industries, including coal, fertilisers and others. These industries have over 40% weightage in the index of industrial production (IIP).
⭐ SEBI gives go-ahead to three IPOs
As many as three companies have received a go-ahead from market regulator SEBI to raise funds through IPO. Staffing firm FirstMeridian Business Services, gas distributor IRM Energy and textile machinery firm Lohia Corp have received go-ahead to float initial share-sale.
Global markets (at 9:30 AM today)
| Indices | Today's movement |
| SGX Nifty | ▲0.42% |
| Nikkei 225 (Japan) | ▲0.15% |
| Hang Seng (Hong Kong) | ▲3.37% |
| SSE Composite (China) | ▲0.89% |
| Dow Jones (US) (February 28) | ▼ 0.71% |
| NYSE (US) (February 28) | ▼ 0.45% |
| Nasdaq (US) (February 28) | ▼ 0.10% |
| S&P 500 (US) (February 28) | ▼ 0.30% |
Fact of the day
As per a new industry report, 5G services could contribute $450 billion to India’s GDP by 2040
Source: Business Standard